Wellington Management Group LLP 13D and 13G filings for Akebia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-10 07:57 am Sale | 2021-07-30 | 13G | Akebia Therapeutics, Inc. AKBA | Wellington Management Group LLP | 711 0.000% | -12,589,752 (-99.99%) | Filing |
| 2021-02-03 1:33 pm Sale | 2020-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | Wellington Management Group LLP | 12,590,463 8.710% | -5,107,650 (-28.86%) | Filing |